Professor David R. Greaves, University of Oxford, UK, discusses the technology that is enabling him to research tissue repair and chronic inflammation in real time
Discover the latest releases, the hottest topics and the stand-out products of the 47th annual society for neuroscience meeting
SelectScience is pleased to congratulate the latest winners of our reviews competitions
Read this exclusive interview with Louise Kenny, one of the founding directors of the INFANT Centre, to discover how they are using mass spectrometry to research preeclampsia and pre-term birth
Innovators in the fields of fuel, steel and aviation reveal how a low-carbon jet fuel made with steel process gases could revolutionize air travel
Learn about best practices for immune monitoring assays using xMAP® Technology from Luminex
Discover how a research group at the University of Geneva, Switzerland, is using an innovative approach to accelerate therapeutics through the drug development process
Brain cancer researcher, Dr. Raffaella Spina, explains cancer recurrence in glioblastomas and her approaches to fighting it in the laboratory
Dr Jim Huggett, LGC & University of Surrey, discusses the results of a study into international inter-laboratory digital PCR
A population genetics scientist tells SelectScience how she’s combating red mite infestations on chicken farms
The introduction of a digital alert system to monitor patients with sepsis has led to a reduction in deaths and hospital stays
How data management solutions are alleviating bottlenecks in the clinical laboratory and saving hours of analyst time, every day
Stanford University chemists develop a synthetic solution to dwindling supplies of anti-cancer and HIV drugs extracted from marine creatures
Find out how the Department of Laboratory Medicine at La Paz University Hospital is utilizing the Siemens DCA Vantage to improve diabetes monitoring and patient care
Research uncovers new roles of Eph and ephrin signaling in lens health
SelectScience reflects on the biggest and best drug discovery stories of the year
A mass spec scientist, from a world-renowned clinical pathology laboratory, shares the secrets to their success in this exclusive SelectScience interview
AEOL 10150 is currently the only drug being developed by BARDA to address the delayed effects of radiation exposure
